# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Ryan Zimmerman upgrades GE HealthCare Techs (NASDAQ:GEHC) from Neutral to Buy and announces $100 price target.
GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in t...
GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in t...
JP Morgan analyst Robbie Marcus initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Neutral rating and announces ...
Published in Anesthesia and Analgesia, results from the multi-site trial evaluating End-tidal Control software provide compelli...
Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management o...